Cited by 18Medication Adherence and ComplianceCancer survivorship and careMobile Health and mHealth Applications

Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)

Open access
Shelby, Rebecca A., Dorfman, Caroline S., Bosworth, Hayden B., Keefe, Francis, Sutton, Linda, Owen, Lynda, Corsino, Leonor, Erkanli, Alaattin +7 more·2019·Contemporary Clinical Trials

Abstract

Adjuvant endocrine therapy (AET) is used to prevent recurrence and reduce mortality for women with hormone receptor positive breast cancer. Poor adherence to AET is a significant problem and contributes to increased medical costs and mortality. A variety of problematic symptoms associated with AET are related to non-adherence and early discontinuation of treatment. The goal of this study is to test a novel, telephone-based coping skills training that teaches patients adherence skills and techniques for coping with problematic symptoms (CST-AET). Adherence to AET will be assessed in real-time for 18 months using wireless smart pill bottles. Symptom interference (i.e., pain, vasomotor symptoms, sleep problems, vaginal dryness) and cost-effectiveness of the intervention protocol will be examined as secondary outcomes. Participants (N = 400) will be recruited from a tertiary care medical center or community clinics in medically underserved or rural areas. Participants will be randomized to receive CST-AET or a general health education intervention (comparison condition). CST-AET includes ten nurse-delivered calls delivered over 6 months. CST-AET provides systematic training in coping skills for managing symptoms that interfere with adherence. Interactive voice messaging provides reinforcement for skills use and adherence that is tailored based on real-time adherence data from the wireless smart pill bottles. Given the high rates of non-adherence and recent recommendations that women remain on AET for 10 years, we describe a timely trial. If effective, the CST-AET protocol may not only reduce the burden of AET use but also lead to cost-effective changes in clinical care and improve breast cancer outcomes. Trials registration: ClinicalTrials.gov, NCT02707471, registered 3/3/2016.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cct.2018.11.010

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The IGHE and SGHE arms were selected as active comparison groups to address possible non-specific intervention effects.

    “IGHE/SGHE were chosen as active comparison groups to address possible non-specific aspects of intervention effects based on our prior studies36–38.”

    From Improving well-being for individuals with persistent pain after surgery for breast cancer, lobular carcinoma in situ, or ductal carcinoma in situ: A randomized clinical trial (2022) · cites this paper as [38]

    The Materials and Methods (Interventions; page not available) says general health education was chosen as a comparison condition to control for attention and time, supporting the rationale for addressing nonspecific effects. The paper describes one individual, phone-based general-health-education comparison group, not separate IGHE and SGHE arms. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 119 references couldn’t be matched to a known paper.

Research works printed but not linked: 7

  1. [2]Abe O, Abe R, Enomoto K, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 5 14 2005; 365(9472): 1687– 1717. 15894097
  2. [18]Partridge AH, Wang PS, Winer EP, Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2 15 2003; 21(4): 602– 606. 12586795
  3. [20]Thompson AM, Dewar J, Fahey T, Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer. Breast Cancer Symposium. 2007;Abstract 130.
  4. [46]Abernethy AP, Keefe FJ, McCrory DC, Behavioral therapies for the management of cancer pain: A systematic review In: Flor H, Kalso E, Dostrovsky JO, eds. Proceedings of the 11th World Congress on Pain. Seattle, WA: IASP Press, 2006: 789– 798.
  5. [76]Morin CM. Treatment Manuals for Practitioners Insominia: Psychological assessment and management. New York: Guilford Press, 1993.
  6. [86]Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health. 1999/01/01 1999; 14(1): 1– 24.
  7. [116]Makubate B, Donnan PT, Dewar JA, Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. British journal of cancer. 03/21/online 2013; 108: 1515. 23519057 PMC3629427

Cited by

Sorted by citations

Authors
Shelby, R. A., Dorfman, C. S., Bosworth, H. B., Keefe, F., Sutton, L., Owen, L., Corsino, L., Erkanli, A., Reed, S. D., Arthur, S. S., Somers, T., Barrett, N., Huettel, S., Gonzalez, J. M., & Kimmick, G.
Affiliations
Duke University (US)
Corresponding author
Shelby, Rebecca A.
Venue
Contemporary Clinical Trials
Publisher
Elsevier BV
Published
2019-01
Volume
76
Pages
120-131
ISSN
1551-7144 (ISSN-L)
OpenAlex
W2901184135
Cited by
18
References
119
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1
FWCI
1.43
Type
journal article
Language
en
Open access
Locations
  • Contemporary Clinical Trials (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (1R01CA193673-01A1)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
adjuvant endocrine therapy, medication adherence, hormone receptor-positive breast cancer, telephone-delivered intervention, coping skills training, symptom interference, vasomotor symptoms, vaginal dryness, sleep disorders, cost-effectiveness
MeSH terms
Self-Management, Adaptation, Psychological, Breast Neoplasms, Fatigue, Female, Humans, Pain, Sleep Wake Disorders, Sweating, Tamoxifen, Telephone, Vaginal Diseases, Randomized Controlled Trials as Topic, Chemotherapy, Adjuvant, Telemedicine, Arthralgia, Antineoplastic Agents, Hormonal, Hot Flashes, Aromatase Inhibitors, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review